GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Cyclically Adjusted Revenue per Share

PHCUF (PhotoCure ASA) Cyclically Adjusted Revenue per Share : $1.06 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PhotoCure ASA's adjusted revenue per share for the three months ended in Sep. 2024 was $0.424. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1.06 for the trailing ten years ended in Sep. 2024.

During the past 12 months, PhotoCure ASA's average Cyclically Adjusted Revenue Growth Rate was 12.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PhotoCure ASA was 15.00% per year. The lowest was 8.60% per year. And the median was 10.35% per year.

As of today (2024-12-11), PhotoCure ASA's current stock price is $4.48. PhotoCure ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was $1.06. PhotoCure ASA's Cyclically Adjusted PS Ratio of today is 4.23.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.61. And the median was 7.83.


PhotoCure ASA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PhotoCure ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Cyclically Adjusted Revenue per Share Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.83 1.08 1.04 1.09

PhotoCure ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.09 1.35 1.12 1.06

Competitive Comparison of PhotoCure ASA's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Cyclically Adjusted PS Ratio falls into.



PhotoCure ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhotoCure ASA's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.424/133.7000*133.7000
=0.424

Current CPI (Sep. 2024) = 133.7000.

PhotoCure ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.173 98.600 0.235
201503 0.172 99.200 0.232
201506 0.210 100.100 0.280
201509 0.200 100.600 0.266
201512 0.183 100.900 0.242
201603 0.175 102.500 0.228
201606 0.198 103.800 0.255
201609 0.200 104.200 0.257
201612 0.203 104.400 0.260
201703 0.198 105.000 0.252
201706 0.218 105.800 0.275
201709 0.212 105.900 0.268
201712 0.218 106.100 0.275
201803 0.247 107.300 0.308
201806 0.262 108.500 0.323
201809 0.248 109.500 0.303
201812 0.263 109.800 0.320
201903 0.284 110.400 0.344
201906 0.286 110.600 0.346
201909 0.317 111.100 0.381
201912 0.588 111.300 0.706
202003 0.246 111.200 0.296
202006 0.238 112.100 0.284
202009 0.203 112.900 0.240
202012 0.421 112.900 0.499
202103 0.389 114.600 0.454
202106 0.405 115.300 0.470
202109 0.373 117.500 0.424
202112 0.404 118.900 0.454
202203 0.345 119.800 0.385
202206 0.380 122.600 0.414
202209 0.386 125.600 0.411
202212 0.388 125.900 0.412
202303 0.371 127.600 0.389
202306 0.496 130.400 0.509
202309 0.377 129.800 0.388
202312 0.497 131.900 0.504
202403 0.410 132.600 0.413
202406 0.500 133.800 0.500
202409 0.424 133.700 0.424

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PhotoCure ASA  (OTCPK:PHCUF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PhotoCure ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.48/1.06
=4.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.61. And the median was 7.83.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PhotoCure ASA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA Business Description

Industry
Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.